205 related articles for article (PubMed ID: 37878619)
1. Evaluation of the efficacy of using indocyanine green associated with fluorescence in sentinel lymph node biopsy.
da Silva Sá R; Von Ah Rodrigues RF; Bugalho LA; da Silva SU; Pinto Nazário AC
PLoS One; 2023; 18(10):e0273886. PubMed ID: 37878619
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
3. Indocyanine green for sentinel lymph node detection in early breast cancer: Prospective evaluation of detection rate and toxicity-The FLUOBREAST trial.
Ngô C; Sharifzadehgan S; Lecurieux-Lafayette C; Belhouari H; Rousseau D; Bonsang-Kitzis H; Crouillebois L; Balaya V; Oudard S; Lécuru F; Elaidi RT
Breast J; 2020 Dec; 26(12):2357-2363. PubMed ID: 33094498
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green fluorescence versus blue dye, technetium-99M, and the dual-marker combination of technetium-99M + blue dye for sentinel lymph node detection in early breast cancer-meta-analysis including consistency analysis.
White KP; Sinagra D; Dip F; Rosenthal RJ; Mueller EA; Lo Menzo E; Rancati A
Surgery; 2024 Apr; 175(4):963-973. PubMed ID: 38097484
[TBL] [Abstract][Full Text] [Related]
5. Single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles in breast cancer.
Wang ZH; Gang TR; Wu SS; Lu C; Gao GX; Xu W; Ding GQ; Qu X; Zhang ZT
Surg Endosc; 2023 Oct; 37(10):7591-7599. PubMed ID: 37460818
[TBL] [Abstract][Full Text] [Related]
6. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
[TBL] [Abstract][Full Text] [Related]
9. Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
Wess B; Kohler C; Plaikner A; El-Safadi S; Schwandner T; Meinhold-Heerlein I; Favero G
Int J Gynecol Cancer; 2024 May; 34(5):675-680. PubMed ID: 38485222
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
[TBL] [Abstract][Full Text] [Related]
11. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
Knackstedt RW; Knackstedt T; Gastman B
J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
[TBL] [Abstract][Full Text] [Related]
13. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
[TBL] [Abstract][Full Text] [Related]
14. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green detects sentinel lymph nodes in early breast cancer.
Liu J; Huang L; Wang N; Chen P
J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent-guided surgery and the use of indocyanine green sentinel lymph node mapping in the pediatric and young adult oncology population.
Johnston ME; Farooqui ZA; Nagarajan R; Pressey JG; Turpin B; Dasgupta R
Cancer; 2023 Dec; 129(24):3962-3970. PubMed ID: 37740680
[TBL] [Abstract][Full Text] [Related]
18. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.
Hua B; Li Y; Yang X; Ren X; Lu X
World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
World J Surg Oncol; 2014 Sep; 12():290. PubMed ID: 25239029
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
